Data & Intelligence
India 2021 Data Insight
GPs deployed a record USD29.5b in India, targeting longterm technology, healthcare, and infrastructure opportunities
Private capital deal value in India reached new highs in 2020, even as the pandemic and protests over agricultural reform have disrupted consumption patterns and the rollout of new policies. The pace of deal-making reflects investor confidence in the long-term potential of both traditional and new sectors. Pharmaceuticals, a mainstay of the Indian economy, attracted six USD100m+ deals, led by Carlyle’s USD490m commitment to Piramal Pharma and KKR’s USD421m investment in J.B. Chemicals. New technology areas like edtech have also attracted capital as COVID-19 forces more and more activities online. Private capital investors deployed over USD1b in online learning platform Byju’s over the course of 2020. Unacademy, which caters to older students preparing for exams, raised more than USD250m from fund managers, Facebook, and local tech entrepreneurs.
EMPEA Members can log in to receive exclusive access to the full detailed reports (PDF) and underlying data (Excel)
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |

There's more content
for EMPEA Members.
Log in for your exclusive access.

Renuka Ramnath | Founder, Managing Director & Chief Executive Officer, Multiples Alternate Asset Management Private Limited

Brian Lim | Partner and Head of Asia and Emerging Markets, Pantheon Ventures

David Rubenstein | Co-Founder and Co-Executive Chairman, The Carlyle Group

Dr. Andrew Kuper | Founder and CEO, LeapFrog Investments

Torbjorn Caesar | Senior Partner, Actis

Drew Guff | Managing Director & Founding Partner, Siguler Guff & Company